HQ MEDICAL NETHERLANDS B V has a total of 16 patent applications. Its first patent ever was published in 2012. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, measurement and organic fine chemistry are NANJING PET TRACER CO LTD, WANQUAN WANTE PHARMACEUTICAL XIAMEN CO LTD and SHANGHAI XUDONG HAIPU PHARMACEUTICAL CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | United States | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | China | 2 | |
#5 | Netherlands | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Organic fine chemistry | |
#4 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Analysing materials | |
#3 | Peptides | |
#4 | Heterocyclic compounds | |
#5 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Maring Markwin Hendrik | 13 |
#2 | Van Beek Ermond Reijer | 11 |
#3 | Löwik Clemens Waltherus Gerardus | 6 |
#4 | Loewik Clemens Waltherus Gerardus | 4 |
#5 | Löwik Clemens Waltherus Gerardus Maria | 3 |
#6 | Maring Markwin | 2 |
#7 | Van Beek Ermond R | 2 |
#8 | Bangwen Xie | 2 |
#9 | Lowik Clemens Waltherus Gerardus | 1 |
#10 | Beek Ermond Reijer | 1 |
Publication | Filing date | Title |
---|---|---|
NL2022828B1 | Targeting compounds for cancers selected from pancreas, pharynx and larynx, lung, breast, and intestines | |
WO2014123418A1 | Groundbreaking platform technology for specific binding to necrotic cells | |
NL2008241C2 | Cell death probe. |